Coverage
-
July 12, 2016
The AIDS Healthcare Foundation will appeal a California federal judge's decision last week that dismissed the group's antitrust and patent invalidation claims against Gilead Sciences Inc. over HIV treatments, the foundation said on Monday.
4 other articles on this case.
View all »